City ... complettely agree on the value of BP partnering, worth a lot more than just the dough to proceed/complete. Can we get it right this time with valuable endpoints focused and poised for success based on prior data, and conduct a solid study? - of course. It even sounds like there is good collaboration with the FDA toward a positive study. Hopefully, we'll find out more about this, on Thursday.

But ... I would feel a lot better with more seasoned and accomplished experience, leadership, guidance (in-house) in these matters, with a vested interest, and an end goal (purchase) as part of it all.